Rationale of the Week | Based on ADA Standards, what is next med addition?
For last week’s practice question, we quizzed participants on ADA Standards & what is next med addition? 67% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question
Question:
JR has type 2 diabetes and takes Metformin 1000mg BID and sitagliptin (Januvia), A1C 8.1%. GFR 47, UACR 158mg/g. Recent diagnosis of congestive heart failure. These are the medications their insurance covers.
Of the following medications, which addition would most benefit JR?
Answer Choices:
- glipizide (Glucotrol)
- pioglitazone (Actos)
- semaglutide (Ozempic)
- dapagliflozin (Farxiga)
Getting to the Best Answer
For a helpful reference, please see our PocketCards for more information.
Answer 1 is incorrect. 5% chose this answer, “Glipizide (Glucotrol)”. Even though glipizide would help lower blood glucose, considering JL’s CHF and worsening kidney function, it is not the best choice.
Answer 2 is incorrect. 8% of you chose this answer, “pioglitazone (Actos)”. Even though pioglitazone would help lower blood glucose, considering JL’s CHF and worsening kidney function, it is not the best choice.
Answer 3 is incorrect. About 18% of respondents chose this, “Semaglutide (Ozempic)”. Even though semaglutide would help lower blood glucose and would address worsening kidney function, considering JL’s CHF and worsening kidney function, it is not the best choice.
Finally, Answer 4 is correct. 67% chose this answer, “Dapagliflozin (Farxiga)”. YES, GREAT JOB. Dapagliflozin is a SGLT-2i that will help lower blood glucose, address worsening kidney function and CHF. Plus, it is covered by insurance. Considering JL’s health profile, it is the best choice.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Ignite your passion & prepare for Diabetes Certification!
Join our Expert Team at our dynamic Virtual DiabetesEd Training Conference April 16-18th, 2025
Gain fresh insights, practical tools, and a deeper understanding of the latest in person-centered diabetes care. Our expert team brings the ADA Standards of Care to life—covering medications, behavior change, technology, and more! If you’re preparing for the CDCES or BC-ADM exam, this conference—paired with free bonus courses—serves as the ideal study companion!
With interactive co-teaching, we keep sessions engaging, relevant, and fun. Let’s learn and grow together!
Our expert team transforms complex diabetes science into clear, practical insights—keeping it real, engaging, and fun! The faculty includes:
- Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES
- Coach Beverly Thomassian, RN, MPH, CDCES, BC-ADM
- Christine Craig, MS, RD, CDCES
- 3 Days: of critical information delivered by passionate speakers in an engaging and fun format!
- 11 Bonus Online Courses: As a course attendee, you automatically receive a bonus online course bundle of 11 online courses valued at over
Sign up for Diabetes Blog Bytes – we post weekly Blog Bytes that are informative and FREE! Every week we post one exam practice Question of the Week and Rationale of the Week. Sign up below!
Recent Blog Bytes
- Rationale of the Week | Based on ADA Standards, what is next med addition?
- Mindful Eating: A Fresh Approach to Diabetes Management
- Question of the Week | Best approach: Fasting During Ramadan
- Rationale of the Week | What happens when people stop taking GLP /GIPs?
- Breaking Free from Weight-Centric Diabetes Care: What I Wish I Had Known Sooner
The use of DES products does not guarantee the successful passage of the certification exam. CBDCE and ADCES do not endorse any preparatory or review materials for the CDCES or BC-ADM exams, except for those published by CBDCE & ADCES.
![](/wp-content/uploads/2023/01/insta-png-v5.png")
